Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
May - Dec 2012
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2012
Report date:
2012

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
N,N-dimethyl-N'-(2,2,6,6-tetramethylpiperidin-4-yl)propane-1,3-diamine
EC Number:
278-817-9
EC Name:
N,N-dimethyl-N'-(2,2,6,6-tetramethylpiperidin-4-yl)propane-1,3-diamine
Cas Number:
78014-16-1
Molecular formula:
C14H31N3
IUPAC Name:
N-[3-(dimethylamino)propyl]-2,2,6,6-tetramethylpiperidin-4-amine
Test material form:
other: liquid

In vivo test system

Test animals

Species:
mouse
Strain:
CBA/Ca
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Age at study initiation: 1st and 2nd pre-test: 9 - 10 weeks (beginning of treatment); main study: 10 – 11 weeks (beginning of treatment)
- Weight at study initiation:1st and 2nd pre-test: 19.3-19.7 g and 19.9-21-1 g (beginning of treatment); main study: 18.6-23.3 g (beginning of treatment)
- Housing: In groups of 4 (pre-test) and 5 (main study)
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/-2°C°C
- Humidity (%): 45-65%
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: From: 30 May 2012 To: 27 June 2012

Study design: in vivo (LLNA)

Vehicle:
acetone/olive oil (4:1 v/v)
Concentration:
0.5, 1 and 2.5%
No. of animals per dose:
5
Details on study design:
A solubility experiment demonstrated that test item solutions at different concentration could be prepared using acetone:olive oil (4+1 v/v) as vehicle.
Due to the corrosive properties of the test item, test item concentrations of 5 and 10% (w/w) were initially tested in one animal, each, in the pre-experiment. Both animals tested, developed an erythema of the ear skin. The animal treated with a concentration of 5% developed a very slight erythema (score 1) on days 3 and 4. The animal treated with the high dose (10%) developed a slight to well visible erythema (score 1 on days 2, 5 and 6; score 2 on days 3 and 4) and a visible swelling of the ears on day 6. Moreover, the animal developed an increase in ear thickness in 54% compared to pre-treatment value. On day 3 both animals developed signs of systemic toxicity, as indicated by a hunched posture and reduced spontaneous activity.
Therefore, a second pre-test was performed using test item concentrations of 1 and 2.5% (w/w). These animals showed no signs of systemic toxicity or excessive local skin irritation.
Thus, the test item in the main study was assayed at 0.5, 1, and 2.5% (w/w).
Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)

Results and discussion

Positive control results:
The periodic positive control experiment was performed with alpha-Hexyl cinnamaldehyde in acetone:olive oil (4+1 v/v) using CBA/CaOlaHsd mice in April 2012.

In vivo (LLNA)

Resultsopen allclose all
Parameter:
other: disintegrations per minute (DPM)
Remarks on result:
other: Vehicle Control Group (acetone:olive oil (4+1 v/v)): 874 0.5% test item: 786 1% test item: 854 2.5% test item: 2149
Key result
Parameter:
SI
Value:
0.9
Test group / Remarks:
0.5% test item in acetone:olive oil (4+1 v/v)
Key result
Parameter:
SI
Value:
0.98
Test group / Remarks:
1% test item in acetone:olive oil (4+1 v/v)
Key result
Parameter:
SI
Value:
2.46
Test group / Remarks:
2.5% test item in acetone:olive oil (4+1 v/v)

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Remarks:
Migrated information
Conclusions:
The test item was not a skin sensitiser under the test conditions of this study.
Executive summary:

In the study the test item TAT (Triacetonetriamine) dissolved in acetone:olive oil (4+1 v/v) was assessed for its possible skin sensitising potential.

For this purpose a local lymph node assay was performed using test item concentrations of 0.5, 1, and 2.5% (w/w). The highest concentration tested was the highest concentration that could be achieved whilst avoiding systemic toxicity and excessive local skin irritation as confirmed by a pre-experiment.

The animals did not show any signs of systemic toxicity or local skin irritation during the course of the study and no cases of mortality were observed. In this study Stimulation Indices (S.I.) of 0.9, 0.98 and 2.46 were determined with the test item at concentrations of 0.5, 1, and 2.5% (w/w) in acetone:olive oil (4+1 v/v), respectively.

The test item TAT (Triacetonetriamine) was not a skin sensitiser under the test conditions of this study.